Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Sodium Chloride × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Colorectal Neoplasms 3 Brain Neoplasms 3 Pancreatic Neoplasms 2 Pain, Postoperative 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leiomyoma 2 Hodgkin Disease 2 Warts 1 Surgical Wound 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sigmoid Neoplasms 1 Severe Acute Respiratory Syndrome 1 Rectal Neoplasms 1 Radiodermatitis 1 Pharyngitis 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neuroinflammatory Diseases 1 Neoplasms 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Meningioma 1 Melanoma 1 Mastocytosis 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

fludarabine 4 Cisplatin 4 atezolizumab 3 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 entrectinib 2 durvalumab 2 cobimetinib 2 capmatinib 2 alectinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡